We indicated that elevated BRD9 expression was linked to an adverse prognosis, with regards to OS, for adrenocortical carcinoma (ACC), LIHC, mesothelioma (MESO) and sarcoma (SARC) cohorts (Figure 3A). The gene discussed is BRD9; the disease is sarcoma.